Another prevalent type of ataxia, where the therapeutic potential of BDNF has been investigated, is Friedreich’s ataxia (FRDA), which is a hNDD caused by mutations in the FXN gene, causing motor dysfunction, as well as cardiopathies [80]. Here, FXN is linked to Friedreich ataxia.